ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SXTP 60 Degrees Pharmaceuticals Inc

0.2249
0.0019 (0.85%)
시간외 거래
최종 업데이트: 05:30:00
15분 지연
기업명 주식 심볼 시장 주식 타입
60 Degrees Pharmaceuticals Inc SXTP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0019 0.85% 0.2249 05:30:00
개장가 저가 고가 종가 전일 종가
0.232 0.22 0.2545 0.2249 0.223
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/05/202402:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
08/05/202420:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/05/202420:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/04/202420:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/03/202420:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
21/02/202406:00EDGAR2Form 8-K - Current report
20/02/202421:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/02/202421:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
03/02/202405:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202405:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202402:00PRNUSWallachBeth Capital Announce Closing of 60 Degrees..
01/02/202401:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
30/01/202423:45PRNUSWallachBeth Capital Announces Pricing of 60 Degrees..
30/01/202423:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
30/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
23/01/202407:01EDGAR2Form 8-K - Current report
22/01/202421:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
17/01/202404:56EDGAR2Form 8-K - Current report
16/01/202421:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
26/12/202321:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
15/11/202321:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
19/10/202321:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
13/10/202305:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
19/09/202305:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
06/09/202320:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
30/08/202320:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
22/08/202320:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
15/08/202320:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
31/07/202320:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
15/07/202302:30PRNUSWallachBeth Capital Announce Closing Of 60 Degrees..
15/07/202301:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
13/07/202302:45PRNUSWallachBeth Capital Announce Pricing Of 60 Degrees..
13/07/202301:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..